4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001578563-24-000364
CIK 0001534120other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:11 PM ET
Size
8.8 KB
Accession
0001578563-24-000364
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-08-13+72,600→ 72,600 total→ Common Stock (72,600 underlying) - Award
Stock Option (Right to Buy)
2024-08-13+186,700→ 186,700 totalExercise: $9.88Exp: 2034-08-13→ Common Stock (186,700 underlying)
Holdings
- 6
Common Stock
Footnotes (3)
- [F1]The stock option vests 25% on March 28, 2025, and 1/36 monthly thereafter, subject to the Reporting Person's continued service on such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon the vesting date.
- [F3]The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:11 PM ET
- Size
- 8.8 KB